For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230804:nRSD2879Ia&default-theme=true
RNS Number : 2879I Quadrise PLC 04 August 2023
4 August 2023
Quadrise plc
(the "Company" and together with its subsidiaries the "Group" or "Quadrise")
Issue of Share Options and Director/PDMR Dealing
Quadrise, the supplier of MSAR(®) and bioMSAR™ emulsion technology and
fuels, providing innovative lower cost and lower carbon alternatives to fuel
oil and biofuels, announces the grant of an aggregate of 53,555,555 options to
subscribe for new ordinary shares of 1p each in the Company (the "Options") to
directors and employees of the Company in accordance with the provisions of
the Company's Unapproved Share Option Plan 2016 ("2016 Plan") and/or
the Company's Enterprise Management Incentive Share Option Plan ("EMI Plan").
The 2016 Plan and EMI Plan are designed to enable the Company to recruit,
retain and reward key employees of the Group - in doing so aligning their
interests with those of the Company's shareholders and enabling the Group to
preserve cash resources ahead of the commercialisation of the Company's
technology.
Performance Options
Of the Options, a total of 13,500,000 performance share options (the
"Performance Options") have been awarded to executives and employees of the
Company, including awards to certain of the Company's directors and PDMRs in
the amounts set out below.
The award of Performance Options, follows a prior share options award on 1
August 2022 which lapsed unvested on the first anniversary of their grant
date due to their specific performance conditions not having been met. The
Performance Options will vest as to 50% on the first anniversary of grant and
the remaining 50% shall vest on the second anniversary of the date of grant.
All vestings of the Performance Options are subject to the satisfaction of
specific performance conditions prior to the vesting dates. The Performance
Options will be exercisable from vesting until the tenth anniversary of the
date of grant.
Director/PDMR Number of Options Plan Exercise price
Jason Miles 7,500,000 EMI Plan 2.5p
David Scott 1,340,000 EMI Plan 2.5p
Philip Hill 1,350,000 EMI Plan 2.5p
Total 10,190,000 - -
Additional Options
In addition, the Company has also granted a total of a further 4,500,000
Options to Non-Executive Directors of the Company in accordance with the
provisions of the 2016 Plan, in the amounts set out below (the "Additional
Options").
There are no performance conditions to the vesting of the Additional Options,
which will vest as to 50% on the first anniversary of grant and the remaining
50% shall vest on the second anniversary of the date of grant. The Additional
Options will be exercisable from vesting until the eighth anniversary of the
date of grant.
Director Number of Options Plan Exercise price
Andrew Morrison 2,000,000 2016 Plan 2.5p
Laurie Mutch 1,000,000 2016 Plan 2.5p
Philip Snaith 1,000,000 2016 Plan 2.5p
Dilip Shah 500,000 2016 Plan 2.5p
Total 4,500,000 - -
Nominal Value Options
The Company also announces the issue a total of 35,555,555 nominal value
options ("NVOs") to certain of the Company's PDMRs and employees in lieu of an
element of cash remuneration for the financial year ended 30 June 2023. The
NVOs have been issued in accordance with and under the EMI Plan. The NVOs will
vest after 12 months from the date of grant, have no performance conditions
and will be exercisable from vesting until the tenth anniversary of the date
of grant. The issue of NVOs include the following awards to certain of the
Company's PDMRs:
PDMR Number of NVOs Plan Exercise price
Jason Miles 6,666,667 EMI Plan 1.0p
David Scott 6,111,111 EMI Plan 1.0p
Philip Hill 3,333,333 EMI Plan 1.0p
Total 16,111,111 - -
Total share options in issue
Following the grant of Options, the Company has a total of 89,319,366 options
to subscribe for new ordinary shares in the Company in issue, representing
approximately 5.72% of the Company's current issued ordinary share capital.
The notifications below, made in accordance with the requirements of the
Market Abuse Regulation, provide further details.
Andrew Morrison, Chairman of Quadrise commented:
"The issue of performance options at a 100% premium to the recent open offer
price is designed to provide an appropriate incentive to achieve performance
metrics and to deliver shareholder value, whilst the issue of nominal value
options further strengthens alignment with shareholders whilst preserving the
Company's cash resources."
For further information, please refer to the Company's website
at www.quadrise.com (http://www.quadrise.com) or contact:
Quadrise Plc
Andrew Morrison,
Chairman
+44 (0)20 7031 7321
Jason Miles, Chief Executive Officer
Nominated Adviser
Cenkos Securities plc
Ben
Jeynes
+44 (0)20 7397 8900
Katy Birkin
Joint Broker
Shore Capital Stockbrokers Limited
Toby
Gibbs
+44 (0)20 7408 4090
Fiona Conroy
VSA Capital Limited +44 (0)20 3005 5000
Andrew Raca (Corporate Finance)
Andrew Monk (Corporate broking)
Public & Investor Relations
Vigo Consulting
Patrick
D'Ancona
+44 (0)20 7390 0230
Charlie Neish
The following notifications are intended to satisfy the Company's obligations
under Article 19(3) of the Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name 1. Jason Miles
2. Jason Miles
3. David Scott
4. David Scott
5.. Philip Hill
6. Philip Hill
7. Andrew Morrison
8. Laurie Mutch
9. Philip Snaith
10. Dilip Shah
2 Reason for notification
a) Position/Status 1. Chief Executive Officer
2. Chief Executive Officer
3 Chief Financial Officer
4. Chief Financial Officer
5. Chief Operating Officer
6. Chief Operating Officer
7. Non-Executive Chairman
8. Non-Executive Director
9. Non-Executive Director
10. Non-Executive Director
Initial notification/amendment Initial notifications
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Quadrise plc
b) LEI 213800HN2ETG5476U328
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Ordinary shares of 1 pence each
code
ISIN: GB00B11DDB67
b) Nature of transaction Awards of options to subscribe for new ordinary
shares under the Quadrise Unapproved Share Option Plan 2016 and/or the
Quadrise Enterprise Management Incentive Share Option Plan.
c) Price(s) and volume(s) Price(s) Volume(s)
1. Nil 1. 7,500,000
2. Nil 2. 6,666,667
3. Nil 3. 1,340,000
4. Nil 4. 6,111,111
5. Nil 5. 1,350,000
6. Nil 6. 3,333,333
7. Nil 7. 2,000,000
8. Nil 8. 1,000,000
9. Nil 9. 1,000,000
10. Nil 10. 500,000
d) Aggregated information n/a
e) Date of transaction 3 August 2023
f) Place of transaction Outside of a trading venue
d)
Aggregated information
n/a
e)
Date of transaction
3 August 2023
f)
Place of transaction
Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPJMLTMTIMBRJ